THNR vs. IBIC
THNR (Amplify Weight Loss Drug & Treatment ETF) and IBIC (iShares iBonds Oct 2026 Term TIPS ETF) are both exchange-traded funds - THNR is a Health & Biotech Equities fund tracking the VettaFi Weight Loss Drug & Treatment Index, while IBIC is a Inflation-Protected Bonds fund tracking the ICE 2026 Maturity US Inflation-Linked Treasury Index. Both are passively managed. Over the past year, THNR returned 8.57% vs 4.54% for IBIC. At a correlation of -0.13, they often move in opposite directions. THNR charges 0.59%/yr vs 0.10%/yr for IBIC.
Performance
THNR vs. IBIC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, THNR achieves a -5.67% return, which is significantly lower than IBIC's 2.37% return.
THNR
- 1D
- -0.50%
- 1M
- -3.61%
- YTD
- -5.67%
- 6M
- -4.62%
- 1Y
- 8.57%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IBIC
- 1D
- 0.02%
- 1M
- 0.27%
- YTD
- 2.37%
- 6M
- 2.51%
- 1Y
- 4.54%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
THNR vs. IBIC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
THNR Amplify Weight Loss Drug & Treatment ETF | -5.67% | 13.65% | -10.36% |
IBIC iShares iBonds Oct 2026 Term TIPS ETF | 2.37% | 4.96% | 3.55% |
Correlation
The correlation between THNR and IBIC is -0.20, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.20 |
Correlation (All Time) Calculated using the full available price history since May 22, 2024 | -0.13 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
THNR vs. IBIC — Risk / Return Rank
THNR
IBIC
THNR vs. IBIC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amplify Weight Loss Drug & Treatment ETF (THNR) and iShares iBonds Oct 2026 Term TIPS ETF (IBIC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| THNR | IBIC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -4.60 | ||
| Sortino ratioReturn per unit of downside risk | -8.35 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 2.24 | -1.15 |
| Calmar ratioReturn relative to maximum drawdown | 0.71 | 17.27 | -16.56 |
| Martin ratioReturn relative to average drawdown | 1.62 | 67.45 | -65.83 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| THNR | IBIC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.45 | 5.05 | -4.60 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.10 | 3.49 | -3.59 |
Drawdowns
THNR vs. IBIC - Drawdown Comparison
The maximum THNR drawdown since its inception was -32.51%, which is greater than IBIC's maximum drawdown of -0.90%. Use the drawdown chart below to compare losses from any high point for THNR and IBIC.
Loading charts...
Drawdown Indicators
| THNR | IBIC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -32.51% | -0.90% | -31.61% |
Max Drawdown (1Y)Largest decline over 1 year | -12.06% | -0.26% | -11.80% |
Current DrawdownCurrent decline from peak | -13.43% | -0.13% | -13.30% |
Average DrawdownAverage peak-to-trough decline | -12.25% | -0.10% | -12.15% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.31% | 0.07% | +5.24% |
Volatility
THNR vs. IBIC - Volatility Comparison
Amplify Weight Loss Drug & Treatment ETF (THNR) has a higher volatility of 5.16% compared to iShares iBonds Oct 2026 Term TIPS ETF (IBIC) at 0.33%. This indicates that THNR's price experiences larger fluctuations and is considered to be riskier than IBIC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| THNR | IBIC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.16% | 0.33% | +4.83% |
Volatility (6M)Calculated over the trailing 6-month period | 13.37% | 0.67% | +12.70% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.16% | 0.90% | +18.26% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.35% | 1.58% | +17.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.35% | 1.58% | +17.77% |
THNR vs. IBIC - Expense Ratio Comparison
THNR has a 0.59% expense ratio, which is higher than IBIC's 0.10% expense ratio.
Dividends
THNR vs. IBIC - Dividend Comparison
THNR's dividend yield for the trailing twelve months is around 1.74%, less than IBIC's 3.59% yield.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
IBIC iShares iBonds Oct 2026 Term TIPS ETF | 3.59% | 4.43% | 4.65% | 0.83% |
THNR Amplify Weight Loss Drug & Treatment ETF | 1.74% | 1.64% | 0.98% | 0.00% |
Frequently Asked Questions
THNR and IBIC have a correlation of -0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
THNR has higher volatility (5.16%) compared to IBIC (0.33%). In terms of maximum drawdown, THNR dropped -32.51% vs IBIC's -0.90%.
On 1-year performance, THNR leads with 8.57% vs 4.54% for IBIC. On fees, IBIC is cheaper at 0.10% per year. On volatility, IBIC has been the lower-risk option at 0.33%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, THNR has performed better with a 8.57% return vs 4.54%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IBIC is cheaper with a 0.10% expense ratio, compared with 0.59% for THNR.
IBIC has the higher dividend yield at 3.59%, compared with 1.74% for THNR.
THNR is categorized as Health & Biotech Equities, while IBIC is Inflation-Protected Bonds. THNR tracks VettaFi Weight Loss Drug & Treatment Index, while IBIC tracks ICE 2026 Maturity US Inflation-Linked Treasury Index. They also come from different issuers: Amplify and iShares. Their fees differ too: 0.59% for THNR and 0.10% for IBIC.
IBIC currently has the higher Sharpe Ratio (5.05 vs 0.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for THNR and IBIC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer